Ovarian cancer

Radiol Clin North Am. 2007 Jan;45(1):149-66. doi: 10.1016/j.rcl.2006.10.012.


Imaging has become an essential part of the clinical management of patients with ovarian cancer, contributing to tumor detection, characterization, staging, treatment planning, and follow-up. Imaging findings incorporated into the clinical impression assist in creating a treatment plan specific for an individual patient. Advances in cross-sectional imaging and nuclear medicine (PET) have yielded new insights into the evaluation of tumor prognostic factors. A multimodality approach can satisfy the complex imaging needs of a patient with ovarian cancer; however, the success of such an approach always depends on available resources and on the skills of the physicians involved.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • CA-125 Antigen / analysis
  • Chemotherapy, Adjuvant
  • Contrast Media
  • Female
  • Follow-Up Studies
  • Humans
  • Lymphatic Metastasis / diagnosis
  • Lymphatic Metastasis / pathology
  • Magnetic Resonance Imaging*
  • Middle Aged
  • Neoplasm Recurrence, Local / diagnostic imaging
  • Neoplasm Recurrence, Local / surgery
  • Neoplasm Staging
  • Ovarian Neoplasms / diagnosis*
  • Ovarian Neoplasms / diagnostic imaging
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / surgery
  • Ovary / pathology
  • Positron-Emission Tomography*
  • Prognosis
  • Risk Factors
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed*
  • Ultrasonography*
  • Ultrasonography, Doppler, Color


  • CA-125 Antigen
  • Contrast Media